{"id":477233,"date":"2020-04-01T17:32:01","date_gmt":"2020-04-01T17:32:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=477233"},"modified":"2020-04-01T17:32:01","modified_gmt":"2020-04-01T17:32:01","slug":"dravet-syndrome-market-size-share-trend-epidemiology-market-forecast-to-2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/dravet-syndrome-market-size-share-trend-epidemiology-market-forecast-to-2030_477233.html","title":{"rendered":"Dravet Syndrome Market Size, Share, Trend, Epidemiology & Market Forecast to 2030"},"content":{"rendered":"
\"Dravet<\/a><\/p>\n
\n
Delveinsight Business Research<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Dravet Syndrome Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Dravet Syndrome, historical and forecasted epidemiology as well as the Dravet Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<\/div>\n

The Dravet Syndrome market report covers emerging drugs, current treatment practices, Dravet Syndrome market share of the individual therapies, current and forecasted Dravet Syndrome Market Size from 2017 to 2030 segmented by seven major markets. <\/p>\n

The report also provides detailed current Dravet Syndrome treatment practice\/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market. <\/p>\n

 <\/span><\/span><\/p>\n

Dravet Syndrome Market Key Facts<\/span><\/strong><\/p>\n

As per DelveInsight’s estimates, the total incident population of Dravet Syndrome in the 7 major markets was 36,301 in 2017<\/p>\n

As per DelveInsight’s estimates, the United States accounted for the maximum number of <\/span>Dravet Syndrome <\/span>patients with 20,731 cases in 2017 followed by Germany with 2,896 cases<\/span><\/p>\n

DelveInsight estimates suggest that Missense mutation was found to have the highest number of incident cases among <\/span>Dravet Syndrome <\/span>patient population in the US<\/span><\/p>\n

 \"\"<\/span><\/span><\/p>\n

Visit For Sample Pages: <\/span><\/strong><\/p>\n

https:\/\/www.delveinsight.com\/sample-request\/dravet-syndrome-market<\/a><\/strong><\/p>\n

 <\/strong><\/p>\n

Key Benefits of Dravet Syndrome Market Report<\/span><\/strong><\/p>\n

Dravet Syndrome market report provides an in-depth analysis of Dravet Syndrome Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.<\/span><\/p>\n

The Dravet Syndrome market report will help in developing business strategies by understanding the Dravet Syndrome Market trends & developments, key players and future market competition that will shape and drive the Dravet Syndrome market in the upcoming years.<\/p>\n

The Dravet Syndrome market report covers Dravet Syndrome current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.<\/p>\n

The report provides a detailed assessment of the Dravet Syndrome market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population,  comparative analysis of pipeline products with detailed clinical profiles, and other factors. <\/p>\n

 <\/p>\n

Dravet Syndrome Market<\/span><\/a><\/strong><\/p>\n

The Dravet Syndrome market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Dravet Syndrome market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology. <\/span><\/p>\n

 <\/span>The report gives a thorough detail of Dravet Syndrome market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. <\/p>\n

 <\/p>\n

Dravet Syndrome Epidemiology<\/span><\/a><\/strong><\/p>\n

The Dravet Syndrome epidemiology section covers insights about historical and current Dravet Syndrome patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.<\/span><\/p>\n

 <\/span>It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  <\/p>\n

 <\/span><\/p>\n

Dravet Syndrome Drugs Uptake and Key Market Players<\/a><\/strong><\/p>\n

Dravet Syndrome Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Dravet Syndrome market or expected to get launched in the market during the study period. The analysis covers Dravet Syndrome market uptake by drugs; patient uptake by therapies; and sales of each drug.    <\/span><\/p>\n

Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions. <\/span>Some of the emerging therapies in Dravet Syndrome market include  ZX008(fenfluramine), Ataluren and others.<\/span><\/p>\n

Some of the key companies in Dravet Syndrome Market includes PTC Therapeutics, Epygenix Therapeutics, GW Pharmaceuticals and others. <\/span><\/p>\n

 <\/span><\/span><\/p>\n

Table of Content<\/span><\/strong><\/p>\n

1. Key Insights<\/span><\/p>\n

2. Executive Summary <\/span><\/p>\n

3. Dravet Syndrome Competitive Intelligence Analysis<\/span><\/p>\n

4. Dravet Syndrome Market Overview at a Glance<\/span><\/p>\n

5. Dravet Syndrome Disease Background and Overview<\/span><\/p>\n

6. Dravet Syndrome Patient Journey<\/span><\/p>\n

7. Dravet Syndrome Epidemiology and Patient Population<\/span><\/p>\n

8. Dravet Syndrome Treatment Algorithm, Current Treatment, and Medical Practices<\/span><\/p>\n

9. Dravet Syndrome Unmet Needs<\/span><\/p>\n

10. Key Endpoints of Dravet Syndrome Treatment<\/span><\/p>\n

11. Dravet Syndrome Marketed Products<\/span><\/p>\n

12. Dravet Syndrome Emerging Therapies<\/span><\/p>\n

13. Dravet Syndrome Seven Major Market Analysis<\/span><\/p>\n

14. Attribute Analysis<\/span><\/p>\n

15. Dravet Syndrome Market Outlook (7 major markets)<\/span><\/p>\n

16. Dravet Syndrome Access and Reimbursement Overview<\/span><\/p>\n

17. KOL Views on the Dravet Syndrome Market.<\/span><\/p>\n

18. Dravet Syndrome Market Drivers<\/span><\/p>\n

19. Dravet Syndrome Market Barriers<\/span><\/p>\n

20. Appendix<\/span><\/p>\n

21. DelveInsight Capabilities<\/span><\/p>\n

22. Disclaimer<\/span><\/p>\n

 <\/span><\/span><\/p>\n

About <\/span>DelveInsight<\/a><\/strong><\/p>\n

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.<\/span><\/p>\n

 <\/span><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> DelveInsight Business Research LLP<\/a>
Contact Person:<\/strong> Anuj Rawat
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +919650213330
Address:<\/strong>304 S. Jones Blvd #2432
City:<\/strong> Albany
State:<\/strong> New York
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.delveinsight.com\/<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Delveinsight Business Research DelveInsight’s “Dravet Syndrome Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Dravet Syndrome, historical and forecasted epidemiology as well as the Dravet Syndrome market trends in the United States, EU5 (Germany, … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[435,405,406,403,404],"tags":[],"class_list":["post-477233","post","type-post","status-publish","format-standard","hentry","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/477233","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=477233"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/477233\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=477233"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=477233"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=477233"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}